Table 2.
Confidence interval 95%. Adjusted by gender, eczema age of onset and number of siblings
| Factor/ exposure | Severe eczema | Persistent eczema | Severe asthma | Keratoconjunctivitis |
|---|---|---|---|---|
| Maternal eczema | OR 5.45 (2.2-9.8), p <0.01 | aOR 4.65 (1.8-8.8), p =0.03 | OR 1.55 (0,8-4.8), p =0.02 | aOR 1.45 (1.1-5.4), p =0.05 |
| OR 1.56 (0.2-11), p =0.3 | OR 0.93 (0.3-6.6), p =0.4 | |||
| Paternal eczema | OR 2.48 (1.9-6.8), p =0.01 | aOR 1.88 (1.1-5.4), p =0.04 | OR 1.88 (1.3-6.7), p =0.02 | aOR 1.14 (1.0-5.8), p =0.05 |
| OR 0.99 (0.74-10), p =0.7 | OR 0.65 (0,34-7.2), p = 0.5 | |||
| Polysensitization #1 | OR 2.65 (1.4-6.4), p =0.01 | aOR 2.05 (1.2-7.8), p =0.02 | OR 2.13 (1.5-8.4), p =0.02 | aOR 1.65 (1.2-7.6), p =0.03 |
| OR 2.2 (1.7-7.2), p =0.01 | aOR 1.55 (1.1-5.8), p =0.01 | OR 2.05 (0.99-10.1), p = 0.08 | ||
| Polysensitization #2 | aOR 3.33 (1.8-7.5), p =0.01 | OR 3.14 (1.2-6.5), p <0.01 | No significant change | No significant change |
| aOR 2.31 (1.6-7.2), p =0.02 | aOR 2.89 (1.2-5.9), p =0.01 | from model 1 | from model 1 | |
| Socioeconomic stratum | OR 0.82 (0.2-9.8), p =0.4 | OR 0.72 (0.2-8.4), p =0.4 | OR 0.52 (0.2-5.5), p =0.3 | OR 0.52 (0.2-6), p = 0.4 |
| Cigarette smoking | OR 0.95 (0.7-7.7), p =0.2 | OR 1.05 (0.6-6.7), p =0.1 | OR 1.65 (0.73-5.9), p =0.09 | OR 0.6 (0.3-4.7), p = 0.6 |
| Coexistence with pets | OR 0.41 (0.2-6.8), p =0.4 | OR 0.61 (0.3-3.5), p =0.3 | OR 0.53 (0.8-4.5), p =0.3 | OR 0.41 (0.3-7.5), p = 0.7 |
| Eczema onset (>14 or <14) | OR 2.65 (0.8-12.6), p =0.5 | OR 1.65 (0.6-9.1), p =0.3 | OR 2.85 (1.32-5.8), p = 0.02 | aOR 1.65 (0.63-3.1), p = 0.07 |
| OR 1.35 (0,7-4.9), p = 0.3 | ||||
| Severe eczema | N/A | OR 3.65 (1.2-7.8), p <0.01 | aOR 2.65 (1.2-5.3), p =0.03 | OR 2.33 (1.9-6.4), p <0.01 |
| aOR 1.95 (1.5-4.8), p =0.01 | OR 2.68 (1.5-7.1), p = 0.02 | aOR 1.88 (1.2-6.4), p = 0.03 |